NCT02886143

Brief Summary

Urinary retention is a common problem, particularly in hospitalized patients. When a Foley catheter is removed, a patient must be monitored for urinary retention. The usual method is a passive voiding trial where the catheter is removed, the bladder fills with urine and the patient is monitored for voiding over approximately 6 hours. Another option is an active voiding trial where the bladder is filled with saline before the catheter is removed and the patient is immediately assisted to void. This study seeks to determine the effect of active vs passive voiding trials on time to hospital discharge, rate of urinary tract infections, and rate or urinary retention in the general hospitalized population.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Oct 2015

Shorter than P25 for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 31, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 1, 2016

Completed
Last Updated

September 1, 2016

Status Verified

August 1, 2016

Enrollment Period

9 months

First QC Date

July 31, 2016

Last Update Submit

August 28, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • time from removal of Foley catheter until hospital discharge

    time from removal of the Foley catheter until the patient physically leaves the hospital

    approximately one day

Secondary Outcomes (2)

  • urinary tract infection

    within 2 weeks of hospital discharge

  • Urinary retention

    within 2 weeks of hospital discharge

Study Arms (2)

Active Voiding Trial (instillation of sterile saline)

EXPERIMENTAL

Patients randomized to receive an active voiding trial will have the bladder filled with 250-400 cc of sterile saline (or until the bladder was full) via the lumen of the urinary catheter before the urinary catheter is removed. The patient will then be immediately assisted to void. Physician teams will follow a standardized algorithm for the management of urinary retention arising during the study.

Procedure: Active Voiding Trial

Passive Voiding Trial

ACTIVE COMPARATOR

For patients randomized to receive a passive voiding trial, the urinary catheter will be removed, the bladder will fill with urine naturally, and the patient will be assisted to void when he or she reports the urge. To ensure uniformity in the intervention, all voiding trials in the study will be supervised by an experienced nurse who will ensure that the protocol is followed.

Procedure: Passive Voiding Trial

Interventions

Nursing protocol: 1. Instill 250-400 cc of STERILE SALINE via the lumen of the Foley catheter into the bladder via gravity drainage or slow push 2. Clamp the Foley 3. Deflate the catheter balloon and remove the catheter from the bladder. 4. Record the amount of saline that was instilled into the bladder. 5. Immediately assist the patient to void. Report the amount instilled and the amount voided to the physician within one hour a. Unless the patient reports extreme bladder fullness or pain, give the patient one hour to urinate 7\. If the patient fails the voiding trial, the physician will decide to do in and out catheterization or place a new Foley catheter

Active Voiding Trial (instillation of sterile saline)

Nursing protocol: 1. Deflate the catheter balloon and remove the catheter from the bladder. 2. Record the time that the catheter was removed and the time the patient is due to void (approximately 6 hours). 3. 5\. If the patient has not voided within 5 hours, assist the patient to try to void. 6\. If the patient is unable to void, is only voiding in small amounts, or reports fullness or abdominal pain, perform a bladder scan. 7\. If the patient has not voided after 6 hours, report this to the physician along with the results of the bladder scan 8. The physician will decide to do in and out catheterization or place a new Foley catheter

Passive Voiding Trial

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admission to one of three hospital units at the University of Virginia (5 Central, 6 West, or the Short Stay Unit)
  • Patient has a Foley urethral catheter in place
  • The physician has ordered the Foley urethral catheter to be discontinued
  • years of age and older

You may not qualify if:

  • Age less than 18 years
  • Prisoners
  • Women who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Mills JT, Rapp DE, Shaw NM, Hougen HY, Agard HE, Case RM Jr, McMurry TL, Schenkman NS, Krupski TL. Effect of active versus passive void trials on time to patient discharge, urinary tract infection, and urinary retention: a randomized clinical trial. World J Urol. 2020 Sep;38(9):2247-2252. doi: 10.1007/s00345-019-03005-0. Epub 2019 Nov 15.

MeSH Terms

Conditions

Urinary RetentionUrinary Tract Infections

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesInfections

Study Officials

  • Tracey L Krupski, MD, MPH

    University of Virginia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Chair

Study Record Dates

First Submitted

July 31, 2016

First Posted

September 1, 2016

Study Start

October 1, 2015

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

September 1, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share